Clients in the Media

October 20, 2025 | Biolinq
Biolinq’s Jared Tangney on making CGMs unintimidating
MedTech Dive
October 17, 2025 | Grifols
In Brief This Week: Grifols, Fraunhofer, Pacific Edge Diagnostics
360Dx
October 16, 2025 | Cidara Therapeutics
A New Approach to Flu Shots! Dr. Jeff Stein, President & CEO, Cidara Therapeutics
Biotech Nation
October 11, 2025 | MeiraGTx
MeiraGTx Gene Therapy Catches Lilly’s Eye In $475m Pact
Scrip
October 10, 2025 | Biolinq
New Type of Glucose Sensor to Enter US Market  
Medscape
October 10, 2025 | Grifols
The quest to make young blood into a drug
Financial Times
October 10, 2025 | MeiraGTx
Lilly bags eye-catching retinal disease gene therapy from MeiraGTx in $475M deal,”
FierceBiotech
October 9, 2025 | LB Pharmaceuticals
Running out of time’: How LB Pharma landed the first big US biotech IPO since February
Endpoints
October 6, 2025 | Abivax
Top 1% Biotech Abivax Surges On ‘Compelling’ Results In A Highly Watched Disease
Investor's Business Daily
October 6, 2025 | Abivax
Abivax releases more data from major Phase 3 wins in ulcerative colitis
Endpoints